Dr. Joseph O. Lambert, MD
Family Medicine (Family Medicine Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical School at Houston (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 577
Licensed in Texas since 1996, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: University of Texas Medical School at Houston
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
TX license K1233 (first issued 1996; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Texas Health Harris Methodist Fort Worth Fort Worth, TX
- Texas Health Arlington Memorial Hospital Arlington, TX
- Texas Health Harris Methodist Hurst-Euless-Bedford Bedford, TX
- Medical City Alliance Fort Worth, TX
- Medical City North Hills North Richland Hills, TX
Medical groups
- North Hills Family Practice, PA (5 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 577
- Services billed
- 17,364
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 1,265 | 511 |
| Automated urinalysis test | 413 | 249 |
| Established patient office or other outpatient visit, 20-29 minutes | 284 | 209 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 186 | 186 |
| Injection of drug or substance under skin or into muscle | 185 | 82 |
| Detection test by immunoassay with direct visual observation for influenza virus | 160 | 72 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 105 | 90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 88 | 83 |
| Injection, methylprednisolone acetate, 80 mg | 74 | 62 |
| X-ray of chest, 2 views | 69 | 59 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 46 payments worth $759 in total to this clinician.
| Lilly USA, LLC | $191 |
|---|---|
| Pfizer Inc. | $64.20 |
| Otsuka America Pharmaceutical, Inc. | $60.17 |
| Novo Nordisk Inc | $57.42 |
| Springworks Therapeutics, Inc. | $52.58 |
| AbbVie Inc. | $38.99 |
| Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.) | $35.47 |
| Madrigal Pharmaceuticals | $24.82 |
| Food and Beverage | $723 |
|---|---|
| Education | $36.33 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Springworks Therapeutics, Inc. Sep 26, 2025 | Education GOMEKLI · in-kind | $36.33 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $80,272 in research payments for these studies, mostly to the institutions running them.
- A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or O…
Amgen Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.